136 related articles for article (PubMed ID: 29600360)
1. Histopathological Assessment for Esophageal Adenocarcinoma.
Lam AK
Methods Mol Biol; 2018; 1756():67-76. PubMed ID: 29600360
[TBL] [Abstract][Full Text] [Related]
2. Application of Pathological Staging in Esophageal Adenocarcinoma.
Lam AK
Methods Mol Biol; 2018; 1756():93-103. PubMed ID: 29600363
[TBL] [Abstract][Full Text] [Related]
3. Application of Tissue Microarray in Esophageal Adenocarcinoma.
Saremi N; Lam AK
Methods Mol Biol; 2018; 1756():105-118. PubMed ID: 29600364
[TBL] [Abstract][Full Text] [Related]
4. Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.
Karamitopoulou E; Thies S; Zlobec I; Ott K; Feith M; Slotta-Huspenina J; Lordick F; Becker K; Langer R
Am J Surg Pathol; 2014 Nov; 38(11):1551-6. PubMed ID: 25140894
[TBL] [Abstract][Full Text] [Related]
5. Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.
Saliba G; Detlefsen S; Carneiro F; Conner J; Dorer R; Fléjou JF; Hahn H; Kamaradova K; Mastracci L; Meijer SL; Sabo E; Sheahan K; Riddell R; Wang N; Yantiss RK; Lundell L; Low D; Vieth M; Klevebro F
Hum Pathol; 2021 Feb; 108():60-67. PubMed ID: 33221343
[TBL] [Abstract][Full Text] [Related]
6. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
7. Histopathological Assessment for Esophageal Squamous Cell Carcinoma.
Lam AK
Methods Mol Biol; 2020; 2129():7-18. PubMed ID: 32056166
[TBL] [Abstract][Full Text] [Related]
8. Introduction: Esophageal Adenocarcinoma: Updates of Current Status.
Lam AK
Methods Mol Biol; 2018; 1756():1-6. PubMed ID: 29600355
[TBL] [Abstract][Full Text] [Related]
9. Updates in staging and pathologic evaluation of esophageal carcinoma following neoadjuvant therapy.
Zhang X; Jain D
Ann N Y Acad Sci; 2020 Dec; 1482(1):163-176. PubMed ID: 32892349
[TBL] [Abstract][Full Text] [Related]
10. Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.
Omstead AN; Kosovec JE; Matsui D; Martin SA; Smith MA; Aaron Guel D; Kolano J; Komatsu Y; Habib F; Lai C; Christopher K; Kelly RJ; Zaidi AH; Jobe BA
Cancer Invest; 2018; 36(7):363-370. PubMed ID: 30142016
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy.
Beseth BD; Bedford R; Isacoff WH; Holmes EC; Cameron RB
Am Surg; 2000 Sep; 66(9):827-31. PubMed ID: 10993609
[TBL] [Abstract][Full Text] [Related]
12. Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer.
Bollschweiler E; Hölscher AH; Metzger R
Future Oncol; 2010 Jan; 6(1):25-35. PubMed ID: 20021207
[TBL] [Abstract][Full Text] [Related]
13. Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.
Hölscher AH; Drebber U; Schmidt H; Bollschweiler E
Ann Surg; 2014 Nov; 260(5):779-84; discussion 784-5. PubMed ID: 25379849
[TBL] [Abstract][Full Text] [Related]
14. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
Bollschweiler E; Besch S; Drebber U; Schröder W; Mönig SP; Vallböhmer D; Baldus SE; Metzger R; Hölscher AH
Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867
[TBL] [Abstract][Full Text] [Related]
15. Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.
Ilson DH; van Hillegersberg R
Gastroenterology; 2018 Jan; 154(2):437-451. PubMed ID: 29037469
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
17. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
[TBL] [Abstract][Full Text] [Related]
18. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
19. [Esophageal adenocarcinoma: the clinicopathologic features, patterns of lymph node metastasis and its influencing factors].
Wang J; Li N; Wang XF; Jing SW; Yang CR; Wang Y; Cao F; Jiao WP; Wu YJ; Guo Y
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):515-20. PubMed ID: 27531265
[TBL] [Abstract][Full Text] [Related]
20. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
